XAIR (AINostix) Company Projected Revenue

Brandmark of beyondair.net (XAIR)

Beyond Air, Inc. (XAIR) generates revenue through the sale of advanced nitric oxide synthesis systems for clinical and private use. The projected future sales indicator on the GURU.Markets terminal chart reflects revenue dynamics, where the value has stabilized at 0.01. The LungFit product addresses the lung therapy market, including neonatal care, while optimized logistics with buffer stocks completely mitigate the risk of supply chain disruptions.

XAIR - Beyond Air, Inc. Company Expected Sales Volume over the range 07/04/2022 - 11/17/2026

Analytical breakdowns and data insights for company Beyond Air, Inc. (XAIR)

- current price and projected stock value:
Fundamental company analysis:Beyond Air Inc
Brand item of AINostix

The scale of operations at Beyond Air, Inc. correlates directly with the expansion of innovative medical systems. By analyzing the company's planned sales volume, investors assess the expected cash flow from future contracts. This metric measures capitalization potential through revenue forecasts, reflecting market expectations for product commercialization. For XAIR, this indicator depends on the pace of FDA approvals and the deployment of equipment in clinics. The trend of the curve confirms the fundamental stability of the business.

Analysis of competing companies

Company Future Sales Volume DXCM (Dexcom)|Company Future Sales Volume Penumbra PEN|Company Projected Revenue Novanta Photonics NOVT|Haemonetics Corp. (HAE) - Company Expected Sales Volume|Inspire Medical - Projected Sales Volume|Company Expected Sales Volume PROCEPT BioRobotics|CNMD: Projected Sales Volume|Company Revenue Forecast PLSE|INMD (InMode MD) - Projected Sales Volume|Company Future Sales Volume Picard Medical Inc. (PMI)|Projected Sales Volume SRDX|Company Future Sales Volume Senseonics Holdings SENS|Projected Sales Volume NPCE (neuropace.com)|Projected Sales Volume Tactile Systems Technology TCMD|SNWV - Company Projected Revenue|Company Expected Sales Volume Outset Medical Corp|ELMD (Electromed Inc) - Company Future Sales Volume|LENSAR, Inc. - Company Future Revenue|RCEL (AVITA Medical Inc) - Projected Sales Volume|Company Expected Sales Volume profoundmedical.com PROF|Company Projected Revenue Baird Medical (BDMD)|EDAP Medical (EDAP) - Company Sales Forecast|Apyx Medical Corp - Company Future Sales Volume|Projected Sales Volume IceCure Medical, Ltd. ICCM|Pulmonx Corp - Projected Sales Volume|Company Future Sales TELA Bio TELA|CytoSorbents Corporation (CTSO) - Company Projected Revenue|Company Expected Revenue SRTS (Sensus)|Company Projected Revenue zynex.com|Company Future Sales Volume electroCore, Inc. (ECOR)|Projected Sales Volume RBOT|IINN - Company Expected Sales Volume|SeaStar Medical - Company Future Sales Volume|IRIX: Company Revenue Forecast|INBS: Company Future Sales Volume|profusa.com - Company Projected Revenue Volume|STRATA Skin Sciences (SSKN) - Company Projected Revenue|Company Sales Forecast glucotrack.com GCTK|NAOV (nanovibronix.com) - Projected Sales Volume|Company Expected Sales Volume Venus Concept Corporation VERO|Company Future Sales Volume NUWE (nuwellis.com)|Company Projected Revenue Volume AEMD|Company Projected Revenue asensus.com ASXC|AVGR: Company Revenue Forecast|BioSig Technologies, Inc - Projected Sales Volume|Company Future Revenue CUTR (Cutera, Inc)|KNW: Projected Sales Volume|inarimedical.com - Company Future Revenue|NVRO (Nevro Corp) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc. RSLS|Projected Sales Volume SILK